Our fellows and grantees produce ambitious, deeply reported stories in partnership with the Center for Health Journalism on a host of timely health, social welfare and equity topics. In addition, the center publishes original reporting and commentary from a host of notable contributors, focused on the intersection of health and journalism. Browse our story archive, or go deeper on a given topic or keyword by using the menus below.
Drought conditions in parts of Central California have become so harsh that it’s normal to turn on the tap have no coming out. Now, some of the town’s residents will have access to something they haven’t had in months — hot showers.
What’s the price of a human life? In this part of our series “At the Crossroads: The Rise of Hepatitis C and The Fight To Stop It,” we'll tell you what value health economists put on human life.
A woman who had attempted suicide and was rushed to a Los Angeles County hospital was photographed by a nurse, with her image then placed on websites two years later. Her case is an extreme example of how violations against patient privacy have increased, both nationwide and in California.
One evening, a group of researchers hit the club-filled streets of West Hollywood with a specific goal: Find young black men, gay and bisexual, willing to participate in a study on how smartphone apps can help improve overall health and combat diseases such as AIDS and diabetes.
Revolutionary new treatments for hepatitis C have hit the market in just the last few months. But they are so expensive that health insurers are balking at the price. What do the drugs' exorbitant costs mean for patients, and who's paying for such treatments?
Across the country, Indians live urban lives, interwoven into different social fabrics as a result of earlier (arguably unsuccessful) federal programs that sought to familiarize Natives with the larger society. In other cases, Indians live in rural areas and are remarkably isolated.
Hepatitis C infects an estimated 5 million Americans, although most of them don’t know it. But deaths from hepatitis C are on the rise in baby boomers. And throughout New England, new infections are creeping up among a younger generation.
In just a few weeks, another pharmaceutical company will likely win FDA approval for a new drug to cure hepatitis C. It’s big news for those living with the chronic disease, many of whom have been waiting decades for a cure.
An effort to reduce the number of patients who are "super-utilizers" in Pennsylvania's Lehigh Valley requires providers to enter into what one expert calls the "messy space" — a relationship that's closer and more personal than the traditional doctor-patient relationship.
